C Gisselbrecht
About
In The Last Decade
C Gisselbrecht
34 papers receiving 834 citations
Peers
Comparison fields: 5 of 61
- Pathology and Forensic Medicine 543
- Oncology 451
- Genetics 181
- Immunology 177
- Molecular Biology 152
Countries citing papers authored by C Gisselbrecht
This map shows the geographic impact of C Gisselbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Gisselbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Gisselbrecht more than expected).
Fields of papers citing papers by C Gisselbrecht
This network shows the impact of papers produced by C Gisselbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Gisselbrecht. The network helps show where C Gisselbrecht may publish in the future.
Co-authorship network of co-authors of C Gisselbrecht
This figure shows the co-authorship network connecting the top 25 collaborators of C Gisselbrecht. A scholar is included among the top collaborators of C Gisselbrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Gisselbrecht. C Gisselbrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 87 | |
| 2 | 49 | |
| 3 | 80 | |
| 4 | 45 | |
| 5 | 69 | |
| 6 | 83 | |
| 7 | 34 | |
| 8 | 20 | |
| 9 | [Aggressive lymphomas]. | 1 |
| 10 | Pancreatic and hepatic plasmocytomas: an exceptional case. | 1 |
| 11 | [Methotrexate-induced skin detachment]. | 11 |
| 12 | 33 | |
| 13 | 19 | |
| 14 | Autoimmune hemolytic anemia disclosing Hodgkin's disease associated with Castleman's disease. | 5 |
| 15 | Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease. | 3 |
| 16 | [Comparison of the antiemetic effectiveness of high-dose corticosteroids with synacthene in nausea induced by chemotherapy: results of a randomized study]. | 2 |
| 17 | [Low-grade non-Hodgkin's lymphoma in the adult: new therapeutic approaches]. | 3 |
| 18 | Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach. | 12 |
| 19 | [Role of chemotherapy in the treatment of cancer of the testis in adults]. | 1 |
| 20 | Maladie de Hodgkin. Masses résiduelles histologiquement non évolutives après chimiothérapie. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.